Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX

CYTORI THERAPEUTICS INC (CYTX)
Mes dernières consult.
Most popular
Rapport
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2017 9,19 M
EBIT 2017 -22,1 M
Net income 2017 -23,6 M
Debt 2017 -
Yield 2017 -
Sales 2018 18,9 M
EBIT 2018 -16,1 M
Net income 2018 -17,1 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 1,84x
Capi. / Sales2018 0,89x
Capitalization 16,9 M
More Financials
Company
Cytori Therapeutics, Inc. is a late stage cell therapy company. that engages in the developement of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.Data from preclinical studies and clinical trials suggest that Cytori Cell... 
Sector
Medical Equipment, Supplies & Distribution
Calendar

- No events available -

More about the company
Surperformance© ratings of Cytori Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on CYTORI THERAPEUTICS INC
10/09 CYTORI THERAPEUTICS INC : Today's Research Reports on Trending Tickers: Cytori T..
10/05 CYTORI THERAPEUTICS : Trademark Application for "CYTORI" Filed by Cytori Therape..
09/21 CYTORI THERAPEUTICS, INC. (NASDAQ : CYTX) Files An 8-K Entry into a Material Def..
09/21 CYTORI THERAPEUTICS, INC. : Entry into a Material Definitive Agreement (form 8-K..
09/11 CYTORI THERAPEUTICS, INC. (NASDAQ : CYTX) Files An 8-K Notice of Delisting or Fa..
09/08 CYTORI THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continue..
09/05 CYTORI THERAPEUTICS, INC. : Other Events (form 8-K)
09/04 BIOTECHNOLOGY MOVERS : Pfizer Inc. (NYSE:PFE) and Cytori Therapeutics (NASDAQ:CY..
09/01 Cytori Announces Corporate Restructuring & Cost Reduction Plan
08/11 CYTORI THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
10/16DJDentsply General Counsel Exits, Marking Fourth Resignation in Recent Weeks --..
10/16DJDentsply Sirona General Counsel Exits, Marking Fourth Resignation in Recent W..
10/13 Toshiba discussing joint investment in chips with Western Digital
10/11 Mondi drags on FTSE, Provident Financial sinks
10/10 SMITH & NEPHEW : Elliott Management builds stake in Smith & Nephew - Bloomberg
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
2016 Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q1 2016 Results - Earnings Ca..
2016 Cytori Therapeutics EPS in-line, beats on revenue
2016 Cytori Cell Therapy an Orphan Drug in Europe for scleroderma-related hand dys..
2016 Notable earnings after Tuesday?s close
2016 Cytori's late-stage study of ECCS-50 in scleroderma 50% enrolled; study to co..
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 2,17 $
Spread / Average Target 346%
EPS Revisions
Managers
NameTitle
Marc H. Hedrick President, Chief Executive Officer & Director
David M. Rickey Chairman
Tiago Girão CFO, Vice President & Head-Investor Relations
John K. Fraser Chief Scientist
Mark T. Marino Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CYTORI THERAPEUTICS INC-4.14%17
MEDTRONIC PLC10.33%106 457
BAXTER INTERNATIONAL43.98%34 785
ZIMMER BIOMET HOLDINGS INC16.95%24 403
C R BARD INC45.55%23 764
HOYA CORPORATION29.67%21 882